Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo Controlled Evaluation, Multicenter Clinical Study of Tongxinluo Capsule in Ischemic Stroke Patients

NCT01919671 is registered in ClinicalTrials.gov with yongjun wang as lead sponsor.

NCT NCT01919671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01919671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo Controlled Evaluation, Multicenter Clinical Study of Tongxinluo Capsule in Ischemic Stroke Patients
Lead sponsor
yongjun wang
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2014
Completion date
November 30, 2016
Enrollment
2,007 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke